Comportamiento suicida y orexina-A en el trastorno bipolar
Autores: Carlota Moya-Lacasa, Mercedes Valtueña, Leticia González-Blanco, Elena Martín Gil, Clara María Álvarez Vázquez, Ainoa García Fernández, Clara Martínez-Cao, Gonzalo Paniagua, Pilar A. Sáiz, Julio Bobes, Paz García-Portilla
Bibliografía
1. Tsuchimine S, Hattori K, Ota M, Hidese S, Teraishi T, Sasayama D, et al. Reduced plasma orexin-A levels in patients with bipolar disorder. Neuropsychiatr Dis Treat., 2019, 15:2221-30.
2. Shariq AS, Rosenblat JD, Alageel A, Mansur RB, Rong C, Ho RC, et al. Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2019; 92:1-7.
3. Brundin L, Björkqvist M, Petersén A, Träskman-Bendz L. Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder. Eur Neuropsychopharmacol. 2007; 17(9): 573-579